2022
Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis
Richman IB, Long JB, Kyanko KA, Xu X, Gross CP, Busch SH. Insurance Coverage Mandates and the Adoption of Digital Breast Tomosynthesis. JAMA Network Open 2022, 5: e224208. PMID: 35333358, PMCID: PMC8956980, DOI: 10.1001/jamanetworkopen.2022.4208.Peer-Reviewed Original ResearchConceptsCoverage mandateCohort studyBreast cancerPocket paymentsDigital breast tomosynthesisInsurance coveragePoints 2 yearsAffordable Care ActMAIN OUTCOMEScreening mammogramsStudy periodDirect costsBreast tomosynthesisPatient ProtectionCare ActWomenCancerAssociationYearsPrivate insurersPatientsCost sharing
2021
Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years
Richman IB, Long JB, Kunst N, Kyanko K, Xu X, Busch S, Gross CP. Trends in Breast Cancer Screening Costs Among Privately Insured Women Aged 40 to 64 Years. JAMA Internal Medicine 2021, 181: 1665-1668. PMID: 34459853, PMCID: PMC8406208, DOI: 10.1001/jamainternmed.2021.4832.Peer-Reviewed Original ResearchComparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old
Richman IB, Long JB, Hoag JR, Upneja A, Hooley R, Xu X, Kunst N, Aminawung JA, Kyanko KA, Busch SH, Gross CP. Comparative Effectiveness of Digital Breast Tomosynthesis for Breast Cancer Screening Among Women 40-64 Years Old. Journal Of The National Cancer Institute 2021, 113: 1515-1522. PMID: 33822120, PMCID: PMC8757313, DOI: 10.1093/jnci/djab063.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiopsyBreastBreast NeoplasmsEarly Detection of CancerFemaleHumansMammographyMass ScreeningMiddle AgedConceptsHigher cancer detection rateCancer detection rateBreast cancer screeningCancer screeningScreening outcomesBreast cancer screening outcomesDigital breast tomosynthesisCancer screening outcomesPopulation-level adoptionReal-world cohortMultivariable logistic regressionHigher biopsy ratesPatient-level analysisPopulation health impactDetection rateIncident cancerClinical outcomesWomen 40Biopsy rateObservational studyComparative effectivenessLogistic regressionYoung womenPrivate health insurersWomenUnderstanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United States
Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Lindau ST, Richman IB, Gross CP. Understanding Regional Variation in the Cost of Breast Cancer Screening Among Privately Insured Women in the United States. Medical Care 2021, 59: 437-443. PMID: 33560712, PMCID: PMC8611614, DOI: 10.1097/mlr.0000000000001506.Peer-Reviewed Original Research
2020
Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation
Aminawung JA, Hoag JR, Kyanko KA, Xu X, Richman IB, Busch SH, Gross CP. Breast cancer supplemental screening: Women’s knowledge and utilization in the era of dense breast legislation. Cancer Medicine 2020, 9: 5662-5671. PMID: 32537899, PMCID: PMC7402830, DOI: 10.1002/cam4.3218.Peer-Reviewed Original ResearchUse and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance
Kunst N, Long JB, Xu X, Busch SH, Kyanko KA, Richman IB, Gross CP. Use and Costs of Breast Cancer Screening for Women in Their 40s in a US Population With Private Insurance. JAMA Internal Medicine 2020, 180: 799-801. PMID: 32202606, PMCID: PMC7147248, DOI: 10.1001/jamainternmed.2020.0262.Peer-Reviewed Original ResearchDense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative Survey
Kyanko KA, Hoag J, Busch SH, Aminawung JA, Xu X, Richman IB, Gross CP. Dense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative Survey. Journal Of General Internal Medicine 2020, 35: 1940-1945. PMID: 31916210, PMCID: PMC7351910, DOI: 10.1007/s11606-019-05590-7.Peer-Reviewed Original Research
2019
Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography.
Busch SH, Hoag JR, Aminawung JA, Xu X, Richman IB, Soulos PR, Kyanko KA, Gross CP. Association of State Dense Breast Notification Laws With Supplemental Testing and Cancer Detection After Screening Mammography. American Journal Of Public Health 2019, 109: 762-767. PMID: 30896987, PMCID: PMC6459654, DOI: 10.2105/ajph.2019.304967.Peer-Reviewed Original ResearchConceptsSupplemental screeningCancer detectionMore breast cancersMagnetic resonance imagingPossible benefitsBreast cancerSupplemental ultrasoundBreast biopsySupplemental testingResonance imagingUse of ultrasoundLogistic regressionScreening mammographyCancer diagnosisUltrasoundSignificant differencesSupplemental testsMore ultrasoundMammographyUS statesBreast cancer detectionMammogramsAssociationScreeningBiopsyNew Breast Cancer Screening Technologies in Older Women—Is It Time to Pump the Brakes?
Richman IB, Gross CP. New Breast Cancer Screening Technologies in Older Women—Is It Time to Pump the Brakes? JAMA Internal Medicine 2019, 179: 289-290. PMID: 30640376, DOI: 10.1001/jamainternmed.2018.7767.Commentaries, Editorials and Letters
2016
Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry
Richman I, Asch SM, Bendavid E, Bhattacharya J, Owens DK. Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry. Journal Of General Internal Medicine 2016, 32: 603-609. PMID: 27844260, PMCID: PMC5442000, DOI: 10.1007/s11606-016-3904-y.Peer-Reviewed Original ResearchConceptsBreast density notification legislationProportion of womenBreast cancer stageCancer stageBreast cancerMetastatic diseaseEnd Results (SEER) Program registryTime of diagnosisInvasive breast cancerBreast density notification lawsSEER registryControl stateDuctal carcinomaInvasive cancerProgram registryAge 40Potential confoundingLimited followSignificant associationIntervention statesDense breastsResultsOur studyCancerDiagnosisEarly detection
2015
Colorectal Cancer Screening in the Era of the Affordable Care Act
Richman I, Asch SM, Bhattacharya J, Owens DK. Colorectal Cancer Screening in the Era of the Affordable Care Act. Journal Of General Internal Medicine 2015, 31: 315-320. PMID: 26349953, PMCID: PMC4762811, DOI: 10.1007/s11606-015-3504-2.Peer-Reviewed Original ResearchConceptsFecal occult blood testAffordable Care ActMedical Expenditure Panel SurveyColorectal cancerBackgroundThe Affordable Care ActNational population-based sampleEvidence-based preventive servicesCRC screening ratesCRC screening servicesOccult blood testRate of colonoscopyUse of colonoscopyPost-ACA periodCare ActPopulation-based sampleCross-sectional analysisColonoscopy useMain MeasuresSelfCRC screeningScreening ratesBlood testsScreening servicesPreventive servicesPrivate health insurancePost-ACA
2012
European genetic ancestry is associated with a decreased risk of lupus nephritis
Richman IB, Taylor KE, Chung SA, Trupin L, Petri M, Yelin E, Graham RR, Lee A, Behrens TW, Gregersen PK, Seldin MF, Criswell LA. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis & Rheumatism 2012, 64: 3374-3382. PMID: 23023776, PMCID: PMC3865923, DOI: 10.1002/art.34567.Peer-Reviewed Original ResearchConceptsSystemic lupus erythematosusRenal diseaseLupus nephritisSLE patientsSingle nucleotide polymorphismsSocioeconomic statusEuropean genetic ancestryCross-sectional studyEuropean ancestrySocioeconomic factorsCandidate risk allelesSubset of participantsMeasures of SESDisease durationLupus erythematosusDecreased riskLogistic regressionDiseaseRisk allelesGenetic ancestryNephritisEuropean descentPatientsCandidate genesAfrican Americans